{"id":"singular","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":["montelukast"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"03957345-ccd0-4def-b528-7733e6a24cbb","title":"SINGULAR WIPES (ALCOHOL) CLOTH [SINGULAR ENTERPRISES LLC]"},"ecosystem":[],"_scrapedAt":"2026-03-28T00:08:15.889Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07135232","phase":"NA","title":"The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health.","status":"RECRUITING","sponsor":"Leeds Beckett University","startDate":"2026-03-01","conditions":"Perimenopause, Menopause","enrollment":72},{"nctId":"NCT06097663","phase":"PHASE2","title":"A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2024-02-15","conditions":"Coronary Heart Disease, Clonal Hematopoiesis of Indeterminate Potential (CHIP)","enrollment":31},{"nctId":"NCT06924021","phase":"","title":"Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2025-05-12","conditions":"Age-Related Macular Degeneration","enrollment":1000},{"nctId":"NCT07495839","phase":"NA","title":"The Impact of Equine-Assisted Therapy on Mental Health and Addictive Behaviors in Patients Receiving Addiction Treatment","status":"NOT_YET_RECRUITING","sponsor":"Hopital La Musse","startDate":"2026-04-01","conditions":"Equine-assisted Therapy, Addiction, Recidivism","enrollment":22},{"nctId":"NCT02466971","phase":"PHASE3","title":"Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-05-10","conditions":"Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma, Advanced Vaginal Squamous Cell Carcinoma","enrollment":450},{"nctId":"NCT04774237","phase":"PHASE2","title":"Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia","status":"COMPLETED","sponsor":"Visus Therapeutics","startDate":"2021-03-24","conditions":"Presbyopia","enrollment":18},{"nctId":"NCT07148089","phase":"PHASE1","title":"A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)","status":"RECRUITING","sponsor":"Solid Biosciences Inc.","startDate":"2026-02-23","conditions":"Catecholaminergic Polymorphic Ventricular Tachycardia","enrollment":18},{"nctId":"NCT06664814","phase":"PHASE2","title":"An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis","status":"RECRUITING","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2026-04-01","conditions":"Focal Segmental Glomerulosclerosis","enrollment":30},{"nctId":"NCT07496697","phase":"NA","title":"Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects","status":"RECRUITING","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2026-03-30","conditions":"Gastrointestinal Motility, Healthy","enrollment":30},{"nctId":"NCT07496073","phase":"PHASE1","title":"A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion in Adult Subjects With Recurrent or Progressive Malignant Primary Brain Tumors（CROWN）","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2026-03-20","conditions":"Brain (Nervous System) Cancers","enrollment":30},{"nctId":"NCT05546554","phase":"PHASE2","title":"Trial of Suvorexant for Sleep in Children With Autism","status":"RECRUITING","sponsor":"Stanford University","startDate":"2023-08-09","conditions":"Autism, Autism Spectrum Disorder","enrollment":26},{"nctId":"NCT07433556","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers","status":"RECRUITING","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2026-03-23","conditions":"Healhty","enrollment":86},{"nctId":"NCT06653842","phase":"PHASE2","title":"A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations","status":"ACTIVE_NOT_RECRUITING","sponsor":"Palvella Therapeutics, Inc.","startDate":"2024-12-20","conditions":"Cutaneous Venous Malformations","enrollment":15},{"nctId":"NCT07494773","phase":"PHASE1, PHASE2","title":"Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection","status":"NOT_YET_RECRUITING","sponsor":"University of Oklahoma","startDate":"2026-06-01","conditions":"Burns, Wound Infection","enrollment":50},{"nctId":"NCT03907475","phase":"PHASE2","title":"Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-16","conditions":"Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm","enrollment":115},{"nctId":"NCT04704661","phase":"PHASE1","title":"Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-08-09","conditions":"Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma","enrollment":51},{"nctId":"NCT07498595","phase":"EARLY_PHASE1","title":"TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University General Hospital","startDate":"2026-03-31","conditions":"EGFR-TKI-resistant Non-Small Cell Lung Cancer","enrollment":50},{"nctId":"NCT03055013","phase":"PHASE3","title":"Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-04-28","conditions":"Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v7","enrollment":819},{"nctId":"NCT07494877","phase":"","title":"Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Infertility","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-09-01","conditions":"Infertility","enrollment":300},{"nctId":"NCT07498166","phase":"NA","title":"Project Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-02-01","conditions":"Achilles Tendon Rupture, Blood Flow Restriction Therapy, Achilles Tendon Repairs/Reconstructions","enrollment":75},{"nctId":"NCT07212257","phase":"NA","title":"Creation of a Pediatric Reference Database for the Kerpape-Rennes-EMG-Based Gait Index","status":"COMPLETED","sponsor":"Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape","startDate":"2024-04-17","conditions":"Healthy Volunteers, Normal Gait, Child Development","enrollment":110},{"nctId":"NCT02146170","phase":"","title":"Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-05-28","conditions":"Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer","enrollment":2000},{"nctId":"NCT07161011","phase":"PHASE2","title":"Phase 2b Controlled Study of Dosing Techniques - Part B","status":"COMPLETED","sponsor":"IVIEW Therapeutics Inc.","startDate":"2025-09-08","conditions":"Dry Eye","enrollment":15},{"nctId":"NCT05837286","phase":"NA","title":"Conservative Treatment of Trigger Finger","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2023-08-01","conditions":"Hand Injuries, Trigger Finger","enrollment":146},{"nctId":"NCT05933954","phase":"NA","title":"The Effects of 5G Radiation on Skin","status":"RECRUITING","sponsor":"Prof. Olivier Gaide, MD-PhD","startDate":"2024-01-09","conditions":"Electromagnetic Radiation (5GFR2)","enrollment":42},{"nctId":"NCT04884594","phase":"PHASE1","title":"AAV8-hCocH for Cocaine Use Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"W. Michael Hooten","startDate":"2021-10-08","conditions":"Cocaine Dependence, in Remission","enrollment":10},{"nctId":"NCT07496632","phase":"NA","title":"Effect of Scalp Block on Intraoperative Hemodynamics and Postoperative Pain in Craniotomy Patients\"","status":"NOT_YET_RECRUITING","sponsor":"Bangladesh Medical University","startDate":"2026-04","conditions":"Scalp Block","enrollment":72},{"nctId":"NCT07493941","phase":"NA","title":"Effect of Bleaching Regimen With Different Activation Modes on Color Stability, Surface Roughness, Tooth Sensitivity and Patient Satisfaction","status":"ENROLLING_BY_INVITATION","sponsor":"Tanta University","startDate":"2026-01-01","conditions":"Bleaching; Satisfactory, Bleaching Sensitivity, Bleaching Efficacy","enrollment":45},{"nctId":"NCT02579967","phase":"PHASE2","title":"Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-11-19","conditions":"Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases","enrollment":354},{"nctId":"NCT07357909","phase":"PHASE1","title":"Safety Study of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults","status":"NOT_YET_RECRUITING","sponsor":"Yayasan Inovasi Molekuler Indonesia (Indonesia Molecular Innovation Foundation)","startDate":"2026-05-01","conditions":"Healthy Volunteer","enrollment":50},{"nctId":"NCT04665739","phase":"PHASE2","title":"Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-02-03","conditions":"Advanced Lung Neuroendocrine Tumor, Functioning Lung Neuroendocrine Tumor, Locally Advanced Lung Neuroendocrine Neoplasm","enrollment":70},{"nctId":"NCT06787079","phase":"NA","title":"Effect of Kinesio Taping Application in Addition to Pilates Exercises on Core Muscle Thickness, Cognition and Mental Fatigue in Individuals With Non-specific Low Back Pain","status":"COMPLETED","sponsor":"Istanbul Saglik Bilimleri University","startDate":"2025-05-01","conditions":"Low Back Pain, Non Specific Low Back Pain","enrollment":54},{"nctId":"NCT07092813","phase":"PHASE1","title":"Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents","status":"RECRUITING","sponsor":"Iterum Therapeutics, International Limited","startDate":"2026-04","conditions":"Pharmacokinetics After Oral Intake","enrollment":12},{"nctId":"NCT07492381","phase":"NA","title":"A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer","status":"NOT_YET_RECRUITING","sponsor":"ALPFA Medical","startDate":"2026-04","conditions":"Prostate Cancer","enrollment":50},{"nctId":"NCT05377424","phase":"PHASE1, PHASE2","title":"Adenosine 2A Receptor Antagonism and AIH in ALS","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2022-06-21","conditions":"ALS","enrollment":40},{"nctId":"NCT01979523","phase":"PHASE2","title":"Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2013-11-21","conditions":"Recurrent Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7","enrollment":42},{"nctId":"NCT05754957","phase":"PHASE3","title":"A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-04-07","conditions":"Acute Coronary Syndrome","enrollment":14194},{"nctId":"NCT05112601","phase":"PHASE2","title":"Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-06-02","conditions":"Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma","enrollment":81},{"nctId":"NCT03559283","phase":"NA","title":"fNIRS in the Evaluation of Cognitive-motor Interference in Post-stroke Patients","status":"COMPLETED","sponsor":"University Hospital, Limoges","startDate":"2018-11-26","conditions":"D020521","enrollment":11},{"nctId":"NCT07478653","phase":"NA","title":"MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease","status":"NOT_YET_RECRUITING","sponsor":"Oelisoa Andriankaja","startDate":"2026-05-01","conditions":"Obesity, Dental Care for Children","enrollment":50},{"nctId":"NCT04958265","phase":"PHASE3","title":"A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2021-11-17","conditions":"Atypical Hemolytic Uremic Syndrome","enrollment":41},{"nctId":"NCT07061964","phase":"PHASE2","title":"Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-11-25","conditions":"Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8","enrollment":111},{"nctId":"NCT01553214","phase":"PHASE4","title":"Improving White Blood Cell Collection From Healthy Donors","status":"RECRUITING","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2012-12-31","conditions":"Allogeneic Granulocyte Donation","enrollment":1000},{"nctId":"NCT06734039","phase":"NA","title":"Impact of Anatomy-Based Cochlear Implant Programming on Early Performance","status":"ENROLLING_BY_INVITATION","sponsor":"Med-El Corporation","startDate":"2025-11-10","conditions":"Hearing Loss, Unilateral, Cochlear Implants, Hearing Loss, Sensorineural","enrollment":50},{"nctId":"NCT06966700","phase":"PHASE3","title":"A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-06-30","conditions":"Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms","enrollment":2400},{"nctId":"NCT07281638","phase":"NA","title":"Bedside Bike Early Mobilization Program for Inpatients","status":"NOT_YET_RECRUITING","sponsor":"Indiana University","startDate":"2026-07-05","conditions":"Immobility Syndrome, Deep Venous Thrombosis, Delirium","enrollment":80},{"nctId":"NCT07498010","phase":"PHASE2","title":"Doxycycline Use in Post-Operative Seromas","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-05","conditions":"Seroma, Post Operative Seroma","enrollment":10},{"nctId":"NCT07388550","phase":"PHASE1","title":"Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2026-04-01","conditions":"Post-Acute COVID-19 Syndrome","enrollment":15},{"nctId":"NCT07450833","phase":"PHASE1","title":"Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers","status":"COMPLETED","sponsor":"Benfovir AG","startDate":"2022-03-01","conditions":"Healthy Volunteers","enrollment":48},{"nctId":"NCT07395258","phase":"PHASE1","title":"A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)","status":"NOT_YET_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2026-03-30","conditions":"Solid Tumors","enrollment":60},{"nctId":"NCT07496190","phase":"PHASE2","title":"Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-03-01","conditions":"Nasopharyngeal Cancinoma (NPC)","enrollment":59},{"nctId":"NCT06099015","phase":"","title":"Cera™ Vascular Plug System Post-Market Clinical Follow-Up","status":"RECRUITING","sponsor":"Lifetech Scientific (Shenzhen) Co., Ltd.","startDate":"2024-06-21","conditions":"Aneurysm, Endoleak, Pulmonary Arteriovenous Malformation","enrollment":132},{"nctId":"NCT05171114","phase":"NA","title":"Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.","status":"COMPLETED","sponsor":"University Hospital, Limoges","startDate":"2021-12-28","conditions":"Scleroderma, Systemic","enrollment":30},{"nctId":"NCT07497620","phase":"PHASE4","title":"Bimzelx (Bimekizumab) For The Treatment Of Adult Onset PRP","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-07-01","conditions":"Pityriasis Rubra Pilaris","enrollment":12},{"nctId":"NCT05222620","phase":"PHASE2","title":"SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2022-03-14","conditions":"Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm","enrollment":90},{"nctId":"NCT06161506","phase":"PHASE2","title":"Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-02-15","conditions":"Urinary Urge Incontinence, Stress Urinary Incontinence, Prostatic Hyperplasia","enrollment":41},{"nctId":"NCT06980038","phase":"PHASE2","title":"Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-08-21","conditions":"Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma","enrollment":44},{"nctId":"NCT06134440","phase":"NA","title":"ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study","status":"TERMINATED","sponsor":"Istituto Oncologico Veneto IRCCS","startDate":"2023-11-21","conditions":"Colorectal Adenocarcinoma","enrollment":71},{"nctId":"NCT06223568","phase":"PHASE2","title":"Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-06-10","conditions":"Squamous Cell Carcinoma of the Head and Neck, Oropharynx, Human Papillomavirus Viruses","enrollment":70},{"nctId":"NCT07495397","phase":"NA","title":"Single-arm, Prospective Clinical Trial of Efficacy and Safety of Daphnetin Capsules Combined With TC Regimen for Targeted Maintenance Therapy After Initial Treatment of Stage III-IV Epithelial Ovarian Cancer (RO/R1)","status":"RECRUITING","sponsor":"The First Hospital of Jilin University","startDate":"2025-11-01","conditions":"Epithelial Ovarian Cancer","enrollment":98},{"nctId":"NCT06126276","phase":"PHASE2","title":"Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-05-07","conditions":"Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm, Recurrent Malignant Female Reproductive System Neoplasm","enrollment":70},{"nctId":"NCT07427680","phase":"PHASE1, PHASE2","title":"Study of TGM-312-SC01 in Healthy Participants and Adults With MASH","status":"RECRUITING","sponsor":"Tangram Therapeutics Plc","startDate":"2026-02","conditions":"Healthy Participants, MASH - Metabolic Dysfunction-Associated Steatohepatitis","enrollment":99},{"nctId":"NCT07498660","phase":"NA","title":"PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial)","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2026-04-01","conditions":"Osteoarthitis, Sacro Iliac Joint Pain, Hip Arthroplasty, Total","enrollment":60},{"nctId":"NCT07347808","phase":"PHASE1","title":"A Pharmacokinetic Study of VCT220 With Moderate Renal Impairment Patients","status":"COMPLETED","sponsor":"Vincentage Pharma Co., Ltd","startDate":"2025-12-25","conditions":"Obesity & Overweight","enrollment":16},{"nctId":"NCT05593497","phase":"PHASE2","title":"A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-05-31","conditions":"High-Risk Prostate Cancer","enrollment":30},{"nctId":"NCT01036685","phase":"","title":"Cognitive Task Development and Implementation for Functional MRI Studies","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2005-05-22","conditions":"Drug Abuse, Nicotine Dependence","enrollment":525},{"nctId":"NCT04090398","phase":"PHASE2","title":"Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-08-04","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone","enrollment":70},{"nctId":"NCT06898606","phase":"PHASE1, PHASE2","title":"Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression","status":"RECRUITING","sponsor":"Federal University of Latin American Integration","startDate":"2024-09-05","conditions":"Depressive Disorder","enrollment":24},{"nctId":"NCT06413498","phase":"PHASE3","title":"A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Kite, A Gilead Company","startDate":"2024-08-23","conditions":"Multiple Myeloma","enrollment":450},{"nctId":"NCT07496996","phase":"NA","title":"PRACOH Prevention Breakdown Support Advice Guidance Disability","status":"NOT_YET_RECRUITING","sponsor":"Pôle Saint Hélier","startDate":"2026-04","conditions":"Person With a Disability, Caregiver","enrollment":100},{"nctId":"NCT06706518","phase":"","title":"Systematic Workflow for Pentaspline Pulsed-field Ablation Optimization","status":"COMPLETED","sponsor":"Daniel Rodríguez Muñoz","startDate":"2023-08-17","conditions":"Atrial Fibrillation (Paroxysmal), Atrial Fibrillation (AF), Ablation of Atrial Fibrillation","enrollment":118},{"nctId":"NCT07497269","phase":"NA","title":"Conventional vs Pulsed RF in Coccydynia","status":"NOT_YET_RECRUITING","sponsor":"Adana City Training and Research Hospital","startDate":"2026-04-01","conditions":"Back Pain","enrollment":90},{"nctId":"NCT07495059","phase":"NA","title":"Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-03-01","conditions":"HIV (Human Immunodeficiency Virus), Continuum of Care, Stigma","enrollment":80},{"nctId":"NCT06154252","phase":"PHASE2, PHASE3","title":"RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy","status":"RECRUITING","sponsor":"Cabaletta Bio","startDate":"2023-12-20","conditions":"Idiopathic Inflammatory Myopathy, Dermatomyositis, Anti-Synthetase Syndrome","enrollment":74},{"nctId":"NCT07497425","phase":"NA","title":"Neuroimmune Responses to Exercise in Chronic Back Pain","status":"RECRUITING","sponsor":"McGill University","startDate":"2025-06-01","conditions":"Chronic Low Back Pain (CLBP)","enrollment":216},{"nctId":"NCT02496208","phase":"PHASE1","title":"Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-07-22","conditions":"Bladder Small Cell Neuroendocrine Carcinoma, Bladder Squamous Cell Carcinoma, Bladder Urothelial Carcinoma","enrollment":152},{"nctId":"NCT06982222","phase":"PHASE1","title":"Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-03-31","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Non-Small Cell Carcinoma","enrollment":24},{"nctId":"NCT07055581","phase":"PHASE2","title":"Durvalumab as Consolidation for Patients LS-SCLC","status":"RECRUITING","sponsor":"Qian Chu","startDate":"2026-02-24","conditions":"Small Cell Lung Cancer Limited Stage","enrollment":100},{"nctId":"NCT00092222","phase":"PHASE2","title":"Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2004-10-28","conditions":"Lymphoproliferative Disorder, HHV-8, Malignancy","enrollment":75},{"nctId":"NCT07496866","phase":"NA","title":"Music Induced Modulation of Pressure Pain Sensitivity and Affective Valence, Comparing Silence and Self-Selected Levantine Music","status":"ACTIVE_NOT_RECRUITING","sponsor":"charbel najem","startDate":"2026-02-12","conditions":"Healthy Participants, Healthy Young Adults","enrollment":32},{"nctId":"NCT04097561","phase":"PHASE1","title":"Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-01-13","conditions":"Idiopathic CD4 Lymphopenia","enrollment":20},{"nctId":"NCT02911103","phase":"PHASE1, PHASE2","title":"Deep Brain Stimulation Surgery for Focal Hand Dystonia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2018-01-17","conditions":"Dystonia, Focal Dystonia, Musician's Dystonia","enrollment":5},{"nctId":"NCT03620019","phase":"PHASE2","title":"Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2018-09-10","conditions":"Melanoma Stage Iii, Melanoma Stage Iv, Melanoma","enrollment":25},{"nctId":"NCT07495007","phase":"PHASE1","title":"An Open-label, Randomized, Single-dose, Two-treatment, Four-period, Fully Replicate Crossover Bioequivalence Study in Healthy Female Adult Participants Under Fasting Conditions Comparing the Test Product, Prontogest Solution for IM Injection With the Reference Product, Progesterone Injection","status":"COMPLETED","sponsor":"Zi Diligence Biocenter","startDate":"2025-11-10","conditions":"Bioequivalance, Post-menopause","enrollment":26},{"nctId":"NCT07113743","phase":"PHASE1, PHASE2","title":"Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-09-10","conditions":"Chronic Granulomatous Disease (CGD)","enrollment":10},{"nctId":"NCT04050410","phase":"EARLY_PHASE1","title":"Autonomic Determinants of POTS - Pilot1","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2019-08-27","conditions":"Postural Tachycardia Syndrome","enrollment":48},{"nctId":"NCT03364114","phase":"NA","title":"Endorotor Resection In Refractory Barrett's Dysplasia Patients","status":"TERMINATED","sponsor":"Interscope, Inc.","startDate":"2018-02-09","conditions":"Barrett's Esophagus With Dysplasia","enrollment":15},{"nctId":"NCT07495878","phase":"NA","title":"Educational Cartoon to Reduce Preoperative Anxiety in Children (CALM-KIDS)","status":"RECRUITING","sponsor":"Mehmet Burak Eşkin","startDate":"2026-01-01","conditions":"Pediatric Preoperative Anxiety, Children, Educational Cartoon","enrollment":159},{"nctId":"NCT01038778","phase":"PHASE1, PHASE2","title":"Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-10-29","conditions":"Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7","enrollment":47},{"nctId":"NCT06635447","phase":"PHASE3","title":"Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2024-09-26","conditions":"Breast Cancer","enrollment":258},{"nctId":"NCT06974045","phase":"","title":"Impact of COVID-19 Pandemic on Single-stage Laparoscopic Cholecystectomy and Laparoscopic Common Bile Duct Exploration Service","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2016-04-01","conditions":"Gallstone","enrollment":237},{"nctId":"NCT07495813","phase":"PHASE1","title":"A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2026-03-31","conditions":"Stable Coronary Artery Disease, Healthy Volunteers","enrollment":196},{"nctId":"NCT07331883","phase":"PHASE2","title":"Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-11-17","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":35},{"nctId":"NCT04316546","phase":"PHASE2","title":"MK-7075 (Miransertib) in Proteus Syndrome","status":"RECRUITING","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2022-05-20","conditions":"Proteus Syndrome","enrollment":45},{"nctId":"NCT06547372","phase":"NA","title":"Dietary Intervention on Atopy","status":"RECRUITING","sponsor":"National University of Singapore","startDate":"2024-05-10","conditions":"Atopic Dermatitis, Atopic, Allergic Diseases","enrollment":110},{"nctId":"NCT06274775","phase":"NA","title":"Effect of an Educational Nail Biopsy Video on Pre-operative Anxiety, Health Literacy, and Patient Satisfaction","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2024-04-02","conditions":"Anxiety, Literacy, Satisfaction, Patient","enrollment":30},{"nctId":"NCT06617182","phase":"PHASE2","title":"Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.","status":"RECRUITING","sponsor":"Yongquan Shi","startDate":"2024-09-30","conditions":"Radiation Enteritis","enrollment":150},{"nctId":"NCT01989585","phase":"PHASE1, PHASE2","title":"Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-03-24","conditions":"Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Neoplasm","enrollment":75},{"nctId":"NCT02311374","phase":"EARLY_PHASE1","title":"Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) During Sleep and Wakefulness","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2015-07-28","conditions":"Brain Mapping","enrollment":40},{"nctId":"NCT07497633","phase":"","title":"Spontaneous Coronary Artery Dissection (SCAD) Avatar Study","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-05","conditions":"Spontaneous Coronary Artery Dissection","enrollment":150}],"_emaApprovals":[],"_faersSignals":[{"count":45,"reaction":"FATIGUE"},{"count":44,"reaction":"DRUG INEFFECTIVE"},{"count":43,"reaction":"NAUSEA"},{"count":40,"reaction":"DYSPNOEA"},{"count":36,"reaction":"ASTHMA"},{"count":35,"reaction":"HEADACHE"},{"count":34,"reaction":"COUGH"},{"count":27,"reaction":"DIZZINESS"},{"count":27,"reaction":"VOMITING"},{"count":26,"reaction":"INJECTION SITE PAIN"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":18404,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"singular","genericName":"singular","companyName":"Chinese Academy of Medical Sciences","companyId":"chinese-academy-of-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}